Cambridge Investment Research Advisors’s Aphria Inc. Common Shares APHA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio APHA Stock Details APHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-45,235	Closed	-$831K	–	3200
2021 Q1	$831K	Sell	45,235 -2,902	-6%	-$47K	﹤0.01%	1562
2020 Q4	$333K	Sell	48,137 -20,283	-30%	-$126K	﹤0.01%	2057
2020 Q3	$303K	Buy	68,420 +21,893	+47%	+$102K	﹤0.01%	1926
2020 Q2	$199K	Buy	46,527 +10,191	+28%	+$39.1K	﹤0.01%	2174
2020 Q1	$110K	Sell	36,336 -5,392	-13%	-$21.5K	﹤0.01%	2093
2019 Q4	$218K	Buy	41,728 +4,678	+13%	+$23K	﹤0.01%	2147
2019 Q3	$192K	Buy	+37,050	New	+$235K	﹤0.01%	2137
2019 Q2	–	Sell	-27,082	Closed	-$252K	–	2405
2019 Q1	$252K	Buy	27,082 +3,175	+13%	+$27.9K	﹤0.01%	1918
2018 Q4	$137K	Buy	+23,907	New	+$188K	﹤0.01%	1997

Cambridge Investment Research Advisors's APHA Position: Q2 2021 in Review

Cambridge Investment Research Advisors sold out of Aphria Inc. Common Shares (APHA) in Q2 2021, closing a stake of 45,235 shares — an estimated $831K sold.

Cambridge Investment Research Advisors first reported a position in APHA in Q4 2018 and held it in 9 quarters. The position peaked at $831K in Q1 2021. 0 funds tracked by Wall St. Rank hold APHA as of Q2 2021.

Cambridge Investment Research Advisors reported no remaining Aphria Inc. Common Shares position as of Q2 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 45,235 Aphria Inc. Common Shares shares in Q2 2021, an estimated $831K.
Cambridge Investment Research Advisors first reported a position in Aphria Inc. Common Shares in Q4 2018 and held it in 9 quarters.
Cambridge Investment Research Advisors's Aphria Inc. Common Shares position peaked at $831K in Q1 2021.
0 funds tracked by Wall St. Rank held Aphria Inc. Common Shares as of Q2 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.